Pulmonary fibroblasts regulate extracellular matrix production and degradation; thus, they are critical for maintenance of lung structure, function, and repair. In pulmonary fibrosis, fibroblasts produce excess collagen and form fibrotic foci that eventually impair lung function, but the mechanisms responsible for these alterations are not known. Receptors coupled to the stimulation of cAMP production can inhibit activation of fibroblasts and thereby are antifibrotic. To test whether this signaling pathway is altered in pulmonary fibrosis, we compared the ability of normal adult human pulmonary fibroblasts to generate and respond to cAMP with that of cells isolated from lungs with idiopathic pulmonary fibrosis. Serum-and transforming growth factor (TGF)-␤-stimulated cell proliferation was inhibited ϳ50% by forskolin and ϳ100% by prostaglandin (PG) E 2 in the normal cells but substantially less in the diseased cells. Collagen synthesis was also inhibited Ͼ50% by the same drugs in the normal cells but significantly less so in the diseased cells, despite responding with similar increases in cAMP production. Although expression of protein kinase A (PKA) and cAMPstimulated PKA activity were similar in both the normal and diseased cell types, forskolin-and PGE 2 -stimulated cAMP response element-binding protein (CREB) phosphorylation was decreased in the diseased cell lines compared with the normal cells. cAMP-mediated activation and TGF-␤-mediated inhibition of CREB DNA binding was also diminished in the diseased cells. Thus, pulmonary fibroblasts derived from patients with pulmonary fibrosis are refractory to the inhibition by cAMP due to altered activity of components distal to the activity of PKA, in particular the phosphorylation of CREB.
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Fibroblasts play a critical role in the homeostasis of extracellular matrix (ECM) in the lung. Recruitment, accumulation, and activation of pulmonary fibroblasts contribute not only to normal wound healing but also to the development of interstitial lung diseases, such as idiopathic pulmonary fibrosis (IPF) . No effective therapy currently exists for pulmonary fibrosis (Giri, 2003) . The pathogenesis and biochemical mechanisms that underlie pulmonary fibrosis are incompletely understood, but key pathological features are an increased number of activated fibroblasts, abnormal tissue remodeling, re-epithelialization, and increased collagen deposition (Chapman, 2004) . Fibrosis seems to strongly correlate with the presence and number of foci in which fibroblasts assume a migratory, then a proliferative, and ultimately a profibrotic, myofibroblastic phenotype (Selman et al., 2004) .
The second messenger cAMP can regulate fibroblasts in many tissues. Cellular levels of cAMP represent the balance between formation, which is regulated by G protein-coupled receptors that stimulate (via G s ) or inhibit (via G i ) adenylyl cyclase (AC), and degradation, which occurs via cyclic nucleotide phosphodiesterase (PDE). Increases in cAMP influence growth, death, and differentiated cell functions, primarily (although not exclusively; de Rooij et al., 1998) by promoting phosphorylation of proteins via the activation of cAMP-dependent protein kinase (protein kinase A; PKA). PKA-mediated phosphorylation of cAMP response element-binding protein (CREB) and CREB-mediated regulation of transcription via interaction with cAMP-response elements is a major pathway that alters gene expression (Montminy, 1997) .
Certain prostaglandins, such as prostacyclin and related analogs prostaglandin (PG) E 2 and PG D 2 , inhibit pulmonary fibroblast migration, proliferation, and collagen synthesis (Keerthisingam et al., 2001; Kohyama et al., 2002; Vancheri et al., 2004) . Those agents all activate receptors coupled to G s , implying that cAMP is a negative regulator of fibroblast function. Some evidence suggests the importance of the G s -AC-cAMP pathway in IPF. This includes results showing compromise of this pathway after experimental pulmonary fibrosis induced by the cancer chemotherapeutic drug bleomycin (Giri et al., 1987) and the diminished capacity to generate PGE 2 of fibroblasts from IPF patients due to insufficient induction of cyclooxygenase expression (Wilborn et al., 1995; Keerthisingam et al., 2001) . Moreover, elevation of cAMP production inhibits cell proliferation, collagen synthesis, and the differentiation of pulmonary fibroblasts into profibrogenic myofibroblasts (Kolodsick et al., 2003; Liu et al., 2004) .
One mechanism by which cAMP may regulate fibrogenicity is via interaction with the TGF-␤ signaling pathway. Activation by TGF-␤ of SMAD proteins, such as SMAD3/4, regulates gene expression by promoting SMAD translocation to the nucleus, where SMAD proteins function as transcription factors . TGF-␤/SMAD signaling enhances transcription of numerous genes, including connective tissue growth factor, plasminogen activator inhibitor-1, and various collagen genes . Recent work suggests that activation of the cAMP/PKA signaling pathway inhibits SMAD-mediated transcription by abolishing SMAD interaction with key transcriptional activators (Schiller et al., 2003) .
In the present study, we tested the hypothesis that generation of and/or response to cAMP contributes to altered pulmonary fibroblast function in pulmonary fibrosis. Accordingly, we compared the responses of a human adult pulmonary fibroblast cell line, LL47, isolated from nonfibrotic lung (normal) and cells isolated from the lungs of patients with IPF (diseased). We found that normal and diseased cells generate similar levels of cAMP but that cAMP-elevating agents only inhibit collagen synthesis in the normal fibroblasts and display reduced inhibition of cell proliferation in the diseased fibroblasts. Although normal and diseased cells have similar levels of expression and activity of PKA, the diseased cells displayed less phosphorylation and DNA binding of CREB in response to cAMP-elevating agents. Reduced activation of CREB is predicted to result in greater TGF-␤/SMAD-mediated transcription of profibrotic genes via decreased competition for transcriptional coactivators required for full SMAD3/4 and CREB transcription. These findings imply that a key defect in pulmonary fibroblasts from fibrotic lung is the regulation of the phosphorylation state of CREB.
Materials and Methods
Materials and Cell Culture. Primary antibodies for collagen I, collagen III, PKA catalytic subunit, and ␤-actin were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Primary antibody for serine 133-phosphorylated CREB (pCREB) was obtained from Chemicon International (Temecula, CA). Primary antibody for ␣-smooth muscle (␣-SM) actin was obtained from Cymbus Biotechnology (West Leighigh, UK). Primary antibody for PKA RII subunit was obtained from Upstate Biotechnology (Charlottesville, VA). PKA inhibitor peptide was obtained from U.S. Biochemical Corp. (Cleveland, OH). All other chemicals and reagents were obtained from Sigma-Aldrich (St. Louis, MO). Human adult pulmonary fibroblasts (LL47, LL29, and LL97A cells) were obtained from American Type Culture Collection (Manassas, VA) and were maintained in minimal essential medium (MEM) supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin in a 37°C incubator with 5% CO 2 . Cells were used between passages 6 and 14 for all experiments.
Measurement of cAMP Accumulation. Cells were washed three times with serum and NaHCO 3 -free Dulbecco's modified Eagle's medium supplemented with 20 mM HEPES, pH 7.4, and equilibrated for 30 min. Assay for cAMP accumulation was performed by incubation with drugs of interest and 0.2 mM 3-isobutyl-1-methylxanthine, a PDE inhibitor, for 10 min. To terminate reactions, assay medium was aspirated, and 200 l of lysis buffer (GE Healthcare, Piscataway, NJ) was added. cAMP content of the extract was quantified using the Biotrak EIA kit (GE Healthcare). Data were normalized to the amount of protein per sample, as determined using a dye-binding protein assay (Bio-Rad, Hercules, CA).
Assays of Cell Proliferation. DNA synthesis were assessed by determination of [ 3 H]thymidine incorporation into trichloroacetic acid (TCA)-precipitable material. Cells were suspended in Dulbecco's modified Eagle's medium containing 10% FBS, seeded (10 4 cells/well) in 24-well plates, grown to 60 to 70% confluence, and synchronized by serum deprivation in MEM containing 0.25% FBS for 24 h. MEM was then supplemented with 2.5% FBS (except for unstimulated conditions, when 0.25% FBS was used) for 24 h along with 0.5 mCi of [ 3 H]thymidine/well and drugs of interest. The medium was removed, the cells were washed with ice-cold phosphate-buffered saline, and then incubated with 7.5% TCA for 1 h at 4°C to precipitate the DNA. After 1 h, cells were washed with 7.5% TCA and then 75% ethanol, and samples were left to dry at room temperature. The TCA-precipitated counts were determined by liquid scintillation counting.
Assays of Collagen Synthesis.
[ 3 H]Proline incorporation was measured according to a method modified from that of Guarda et al. (1993) as described previously (Ostrom et al., 2003 Reverse-Transcriptase-Polymerase Chain Reaction. Total RNA was extracted from cells grown to 80 to 90% confluence on 10-cm plates using TRIzol reagent (Invitrogen, Carlsbad, CA) and RNeasy RNA isolation kit (QIAGEN, Valencia, CA). A DNase reaction was performed to eliminate DNA contaminants and the RNA was reverse transcribed using Superscript II (Invitrogen) and poly(dT) primers. Polymerase chain reactions (PCRs) with each primer pair were performed on cDNA, genomic DNA (positive control), and minus reverse-transcriptase (negative control) templates. PCR products were analyzed by agarose gel electrophoresis and visualized under UV light with ethidium bromide. RT-PCR was performed initially to confirm that single PCR products resulted from reactions with each primer pair. Suitable primers were then used in real-time PCR reactions with SYBR Green (Bio-Rad QI Taq SYBR Green). The primers were designed based on GenBank sequences, as described previously (Liu et al., 2004) . The thermal profile for all real-time PCR reactions was 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 10 s and 60 to 62°C for 1 min. Fluorescence data from each sample was analyzed by the 2 Ϫ[⌬⌬Ct] method using the vehicle-treated control as the calibrator:
. GI is the gene of interest, and C t is the Deficient Response to cAMP in Diseased Fibroblasts 679 cycle threshold (the cycle number where the fluorescent signal crosses an arbitrary intensity threshold).
Immunoblot Analysis. Whole-cell lysates were obtained from treated or untreated cells by scraping cells in modified radioimmunoprecipitation assay lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Igepal CA-630, plus mammalian protease inhibitor cocktail; catalog no. P-8340, Sigma-Aldrich) and homogenizing by sonication. For immunoblot of pCREB, cells were lysed in 2ϫ SDS sample buffer and boiled for 5 min. Equal protein amounts of the lysates were separated by SDS-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes (Millipore Corporation, Billerica, MA) by electroblotting. Membranes were blocked in 20 mM phosphate-buffered saline with 3% nonfat dry milk and incubated with primary antibody (see Materials and Methods) overnight at 4°C. Bound primary antibodies were visualized using appropriate secondary antibody with conjugated horseradish peroxidase (Santa Cruz Biotechnology, Inc.) and enhanced chemiluminescence reagent (Pierce Chemical, Rockford, IL). The amount of protein per sample was determined using a dye-binding protein assay (Bio-Rad).
PKA Activity Assay. PKA activity was determined by an enzyme-linked immunosorbent assay-based assay using crude wholecell lysates. Cells were scraped from the plate in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Igepal CA-630 plus mammalian protease inhibitor cocktail as described above), incubated for 10 min, and then homogenized in a Dounce (glass-glass) homogenizer for 20 s on ice. Homogenates were then centrifuged at 300g for 15 min, and the postnuclear supernatant was collected and centrifuged at 5000g for 15 min. PKA activity was measured in the resulting supernatant using a PKA activity assay kit (StressGen Biotechnologies, San Diego, CA), according to the manufacturer's instructions. PKA activity was stimulated by the addition of 0.01 to 5 M cAMP for 5 min at 37°C. Greater than 95% of the measured kinase activity was PKA activity, as determined by pretreating lysates for 20 min with 10 nM PKA inhibitor peptide.
Electromobility Shift Assays. Cells were starved with 0.25% FBS for 24 h, and then cells were treated with either 10 M forskolin or vehicle for 20 min. TGF-␤ 1 (10 ng/ml) or vehicle was then added for another 20 min. Cells were lysed in lysis buffer (20 mM HEPES, pH 7.9, 20% glycerol, 10 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.1% Triton X-100, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride), incubated at 4°C for 5 min, and then centrifuged at 500g for 10 min. Nuclear extraction buffer (20 mM HEPES, pH 7.9, 20% glycerol, 400 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride) was added to resulting pellet and incubated at 4°C with slow rocking for 2 h. Samples were then centrifuged at 12,900g for 10 min. Protein concentration in the nuclear extract was determined using the Bio-Rad dye-binding protein assay. Binding reactions with biotin-labeled probes were run and separated by electrophoresis on 6% polyacrylamide gels as per the manufacturer's protocol (Panomics, Redwood City, CA), and then visualized by chemiluminescence. The specificity of each probe-protein complex was confirmed by supershift assay using a CREB binding protein 1 (CBP-1) antibody.
Data Analysis and Statistics. Data are presented as the mean Ϯ S.E.M. or as representative images of at least three separate experiments. Statistical comparisons (t tests and one-way analysis of variance) and graphics were performed using GraphPad Prism 4.0 (GraphPad Software Inc., San Diego, CA).
Results

cAMP-Elevating Agents Inhibit Pulmonary Fibroblast Proliferation and Collagen Synthesis.
Previous work indicates that cAMP-elevating agents inhibit cell proliferation and collagen synthesis of pulmonary fibroblasts (Lindenschmidt and Witschi, 1985; Liu et al., 2004) . To determine whether fibroblasts from fibrotic lung are less responsive to inhibition by cAMP-elevating agents, we compared [ 3 H]thymidine incorporation (an index of DNA synthesis) and collagenase-sensitive [ 3 H]proline incorporation (an assay of collagen synthesis) in LL47 (normal) and LL29 (diseased) cells. Both cell types were serum-starved for 24 h in 0.25% FBS and then cultured for 24 h with 2.5% FBS (a maximally effective concentration of serum; Liu et al., 2004) and either vehicle or various concentrations of cAMPelevating agonists. In LL29 cells 2.5% FBS was less effective in stimulating [
3 H]thymidine incorporation than in LL47 cells (Fig. 1) , consistent with observations that cells from fibrotic lung are less proliferative (Ramos et al., 2001 ). More impressive differences were noted when we tested agents that directly increase AC activity (e.g., forskolin) or that activate G protein-coupled receptors coupled to G s . Forskolin (1 M) and the prostanoid E receptor agonist PGE 2 (1 M) inhibited FBS-stimulated [
3 H]thymidine incorporation in LL47 cells by 79 Ϯ 15 and 114 Ϯ 16%, respectively. Isoproterenol (1 M), an agonist for ␤-adrenergic receptors linked to increases in cAMP, also inhibited [
3 H]thymidine incorporation (Table 1) . These responses were similar in magnitude to those measured in another normal pulmonary fibroblast cell line, WI-38 (Liu et al., 2004) . None of the agents changed cell number. Thus, numerous approaches that increase 3 H]Thymidine incorporation was measured in LL47 (normal) and LL29 (diseased) cells stimulated by 2.5% FBS in the absence and presence of the indicated concentrations of forskolin (Fsk) or PGE 2 as described under Materials and Methods. Each column represents the mean Ϯ S.E. of six independent experiments. ‫,ء‬ p Ͻ 0.05 compared with 2.5% FBS alone; #, p Ͻ 0.05 compared with unstimulated (0.25% FBS); and †, p Ͻ 0.05 comparing cell types, each using paired t test. The percentage of inhibition of [ 3 H]thymidine incorporation was calculated from these data using the 2.5% FBS level of incorporation as 0% inhibition and the 0.25% FBS level of incorporation as 100% inhibition (inset). ‡, p Ͻ 0.05 comparing cell types using t test. We measured collagenase-sensitive [ 3 H]proline incorporation, an assay of collagen synthesis, to examine a differentiated function of the fibroblasts. As with [
3 H]thymidine incorporation, LL29 cells responded to a smaller extent to stimulation with 2.5% serum than did LL47 cells (Fig. 2) . The reasons for this reduced responsiveness of the diseased cells are not clear, but they may be due to a chronic desensitization to trophic stimuli. Forskolin and PGE 2 inhibited collagenase-sensitive [ 3 H]proline incorporation in LL47 cells, with PGE 2 yielding inhibition at or below the basal activity of the cells (Fig. 2) (Fig. 2) , or isoproterenol (Table 1) . Forskolin-mediated inhibition of collagenase-sensitive [ 3 H]proline incorporation exhibited a biphasic response in LL47 cells (Fig. 2, bottom) . These data were best fit using a two-site model, with Ϫlog IC 50 values of 8.6 Ϯ 1.3 nM and 5.1 Ϯ 0.5 M for the highand low-potency components, respectively. In LL29 cells, forskolin only exhibited a single site concentration response in inhibiting collagen synthesis, with a Ϫlog IC 50 of 5.6 Ϯ 0.4 M. Thus, LL29 cells are less responsive to the inhibition of collagen synthesis by multiple cAMP-elevating agents primarily due to a lack of high-potency responses.
Regulation of cAMP Production in Human Pulmonary Fibroblasts. To determine whether diseased cells produce less cAMP, we measured cAMP accumulation in LL47 and LL29 human pulmonary fibroblasts. Forskolin and PGE 2 each significantly (p Ͻ 0.05) stimulated cAMP production in the presence of a nonselective PDE inhibitor, 3-isobutyl-1-methylxanthine, in both LL47 and LL29 cells (Fig. 3) . Forskolin and PGE 2 displayed similar EC 50 values in both LL47 and LL29 (Ϫlog EC 50 for forskolin: LL47 ϭ 6.47 Ϯ 0.14, LL29 ϭ 6.46 Ϯ 0.16; for PGE 2 : LL47 ϭ 5.87 Ϯ 0.18, LL29 ϭ 5.88 Ϯ 0.13; p Ͼ 0.1 for each comparison). LL29 cells displayed slightly increased basal cAMP production (0.8 Ϯ 0.06 3 H]proline incorporation was calculated from these data using the 2.5% FBS level of incorporation as 0% inhibition and the 0.25% FBS level of incorporation as 100% inhibition (inset). ‡, p Ͻ 0.05 comparing cell types using paired t test. Bottom, percentage of inhibition of collagenase-sensitive [ 3 H]proline incorporation was also measured in response to various concentrations of forskolin. Each column represents the mean Ϯ S.E. of four experiments, and the line represents the fit of each data set using nonlinear regression analysis. Data from LL29 cells was best fit using a one-site model, whereas LL47 cell data were best fit by a two-site model (see Results).
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at ASPET Journals on July 8, 2017 jpet.aspetjournals.org Downloaded from pmol/mg protein for LL47 cells, 1.2 Ϯ 0.08 pmol/mg protein for LL29 cells; p Ͻ 0.05) and slightly increased response to multiple concentrations of both agonists (Fig. 3) . Both normal and diseased cells responded with similar increases in cAMP production when stimulated with isoproterenol (1 M; Table  1 ). Forskolin, PGE 2 , and isoproterenol stimulated cAMP production to a similar magnitude in WI-38 cells, another normal pulmonary fibroblast cell line (Liu et al., 2004) . Thus, compared with normal pulmonary fibroblasts, fibroblasts cultured from human fibrotic lung are not deficient in their ability, and indeed may have a greater capacity, to generate cAMP.
Effect of Forskolin and PGE 2 on Collagen Isoform Expression. We used quantitative real-time RT-PCR to examine whether increased cellular cAMP levels alter expression of specific collagen isoforms in LL47 and LL29 cells and in addition, tested LL97A cells, another pulmonary fibroblast cell line isolated from fibrotic lung. Collagen types I and III are the predominant isoforms produced by pulmonary fibroblasts (Liu et al., 2004) . We isolated total RNA from LL47, LL29, and LL97A cells treated with either vehicle or PGE 2 (1 M) for 24 h and quantified the level of mRNA expression of collagen types I␣1, I␣2, and III␣1. We found that the level of mRNA for all three collagens was 9-to 20-fold higher in the diseased cells than in the normal LL47 cells. Treatment of LL47 cells with PGE 2 decreased collagen type I␣1, I␣2, and III␣1 by 74 to 87%; by contrast, PGE 2 either had no effect or increased mRNA levels of these same genes in LL29 and LL97A cells with LL97A cells showing greater increases than did the LL29 cells (Table 2) . Thus, normal pulmonary fibroblasts respond to PGE 2 with decreased collagen mRNA expression, whereas two different lines of fibroblasts isolated from patients with IPF show unaltered or increased expression of collagen mRNA in response to PGE 2 .
Immunoblot analysis, used to assess levels of expression of collagen I and collagen III in cell lysates after stimulation of cells with 2.5% serum for 24 h, revealed that both collagens were decreased in LL47, but not in LL29 or LL97A, cells incubated with forskolin (1 M) or PGE 2 (1 M) (Fig. 4 ; data not shown). Collagen I and collagen III immunoreactivity were also decreased by forskolin and PGE 2 in another normal pulmonary fibroblast cell line, WI-38 (Liu et al., 2004) . Although treatment with PGE 2 significantly increased collagen mRNA levels in LL29 and LL97A cells ( Table 2 ) the increases in collagen proteins was not as dramatic (Fig. 4) .
Immunoreactivity of ␣-smooth muscle actin (␣-SM actin), a marker of myofibroblasts and indicator of fibroblast-myofibroblast differentiation (Kolodsick et al., 2003) , was decreased by treatment of LL47 and LL29 cells (Fig. 4) , LL97A cells (data not shown), and WI-38 cells (Liu et al., 2004 ) with forskolin or PGE 2 . Thus, the diseased cells are refractory to cAMP-mediated inhibition of collagen synthesis but not to cAMP-mediated inhibition of myofibroblast differentiation.
PKA Expression and CREB Phosphorylation. The data in Figs. 1 to 4 suggest that pulmonary fibroblasts from fibrotic lung are deficient in expression or activity of element(s) "downstream" of cAMP generation that mediate responses regulated by this second messenger. We thus examined expression and activity of PKA, the major mediator of cAMP action. SDS-PAGE and immunoblot analyses of wholecell lysates from LL47 and LL29 cells revealed no detectable differences in the immunoreactivity of either the regulatory or catalytic subunits of PKA between the two cell lines (Fig.  5A ). In addition, enzyme activity in cytosolic fractions from LL47 and LL29 cells was similar, in terms of both basal and cAMP-stimulated PKA activity (Fig. 5B) . cAMP-Stimulated PKA activity was equivalent in a second diseased cell line, LL97A (data not shown). These data suggest that differences in PKA expression and activity do not account for the difference in responses to cAMP-elevating agents.
A key downstream effector of PKA is the transcription factor CREB, whose activity is activated by PKA-promoted phosphorylation of serine 133. We used a monoclonal antibody that recognizes pCREB to assay CREB activation in whole-cell lysates. Vehicle-treated LL29 cells had higher levels of pCREB immunoreactivity, after adjusting for protein loading based upon total CREB immunoreactivity, than did similarly treated LL47 cells (Fig. 6) . Treatment of LL47 cells with 1 M forskolin or 1 M PGE 2 increased pCREB immu- at ASPET Journals on July 8, 2017
jpet.aspetjournals.org Downloaded from noreactivity at 5 min, the earliest time point we measured; forskolin-stimulated pCREB immunoreactivity remained elevated for 3 h, whereas response to PGE 2 was increased for 1 h. By contrast, neither forskolin nor PGE 2 significantly elevated pCREB immunoreactivity over basal levels in LL29 cells at any time point measured. The levels of pCREB immunoreactivity decreased during the 24-h incubation under all conditions, an effect not attributable to decreased cell 
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jpet.aspetjournals.org number or viability. LL97A cells also had diminished PGE 2 -promoted activation of CREB with no significant increase in CREB immunoreactivity over basal (Fig. 6C) . Thus, despite generating equivalent levels of cAMP, similar extents of PKA activation and equivalent levels of total CREB expression (normalized to total protein content), two different diseased pulmonary fibroblast cell lines have an increased "basal" level of CREB phosphorylation and are less responsive to activation of CREB by cAMP-elevating agents than are normal fibroblasts. Recent reports indicate that cAMP-elevating agents inhibit TGF-␤ 1 -induced collagen gene transcription via CREB-mediated sequestration of CBP-1 and p300 (Schiller et al., 2003) , which are coactivators for transcriptional regulation by TGF-␤ acting via SMAD3/4 (Shen et al., 1998) . We used electromobility shift assays to assess impact of increased cAMP production on TGF-stimulated collagen production via effects on transcriptional coactivators and CREB binding to cAMP response element consensus sequences of DNA from pulmonary fibroblasts. Forskolin treatment stimulated CREB DNA binding in normal cells but had no effect in diseased cells, although the diseased cells had an elevated basal level of CREB binding (Fig. 7) . TGF-␤ treatment did not alter basal CREB binding in either the LL29 or LL47 cells but inhibited forskolin-stimulated CREB binding in the LL47 cells. These data are consistent with the idea that SMAD3/4 and CREB compete for transcriptional cofactors and imply that cAMP-PKA signaling reduces expression of profibrotic genes by competing with SMAD3/4 for transcriptional coactivators such as CBP-1 and p300 (Ghosh et al., 2001) . Because the diseased cells (in spite of having higher basal CREB binding) are unresponsive to either forskolin or TGF-␤, we conclude that diminished activation of CREB, deficient stimulation of transcriptional cofactor binding, and decreased inhibition of growth factor-stimulated gene transcription contribute to the refractoriness of fibroblasts from human fibrotic lung to cAMP-mediated inhibition of cell proliferation and collagen synthesis.
Discussion
The present results demonstrate that fibroblasts isolated from fibrotic lung lack responsiveness to a key negative regulator of cell proliferation and collagen synthesis, cAMP, despite generating equivalent or higher levels of this second messenger compared with normal pulmonary fibroblasts. We assessed several types of agents (an AC activator and receptor agonists) and two stimulatory signals (serum and TGF-␤ 1 ) using multiple experimental approaches that all yielded results consistent with this conclusion. We did not observe differences in levels of PKA expression or activity between normal and diseased pulmonary fibroblasts. Instead, our data implicate differences in events distal to cAMP/PKA, in particular the phosphorylation and activation of CREB, as accounting for the decreased response to cAMP-elevating agents in cells from fibrotic lung. Diseased cells displayed elevated basal pCREB levels and CREB binding with no detectible increases in response to increases in cAMP and activation of PKA. In normal pulmonary fibroblasts, the increase in pCREB recruits coactivators such as CBP-1 and p300, sequestering and preventing them from acting as cofactors with transcriptional elements such as SMAD3/4, which stimulate profibrotic gene programs (Shen et al., 1998) . The lack of cAMP-stimulated increases in pCREB levels in fibroblasts from fibrotic lung likely blunts the recruitment of CBP-1 and presumably allows SMAD3/4-mediated transcription to go unchecked. Such a model is consistent with transcriptional regulation that has been demonstrated in other cell types (Ghosh et al., 2001; Schiller et al., 2003) and with defects that have been described in scleroderma, a disorder associated with enhanced fibrosis in the skin, lung, and other sites Asano et al., 2004) . Fibroblasts cultured from such patients produce greater amounts of prostaglandins (which increase cAMP jpet.aspetjournals.org Downloaded from levels) but are refractory to their action in terms of inhibition of formation of connective tissue growth factor, which is produced in response to TGF receptor activation (Stratton et al., 2001) .
Several transcription factors, including CREB, CCAAT binding factor, nuclear factor 1, activator protein 1, and Sp1 are required for expression of collagen genes in fibroblasts (Li et al., 1995; Hasegawa et al., 1996; Fabbro et al., 1999) . Thus, although our studies implicate cAMP as a regulator of transcription of collagen genes, transcriptional regulation of pulmonary fibroblasts likely occurs by factors in addition to CREB and SMAD3/4 and contributes . CREB phosphorylation induced by increased cAMP production is diminished in fibrotic pulmonary fibroblasts. Whole-cell lysates were prepared from LL47, LL29, or LL97A cells treated for the indicated time with either vehicle (control), 1 M forskolin (Fsk, A), or 1 M PGE 2 (B and C) and then separated by SDS-PAGE and analyzed by immunoblot analysis using a monoclonal antibody specific for pCREB. Representative blots from three to five experiments are shown (top). Individual pCREB immunoreactive bands were quantified, adjusted for the density of total CREB immunoreactivity, and are shown as the mean Ϯ S.E. (bottom). ‫,ء‬ p Ͻ 0.05 by paired t test compared with control. †, p Ͻ 0.05 using t test comparing cell types.
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jpet.aspetjournals.org to modulation of collagen synthesis and cell growth in these cells. LL47, LL29, and LL97A cells as well as WI-38 cells (Liu et al., 2004 ) display many of the same qualities as primary human pulmonary fibroblasts: they differentiate into myofibroblasts and produce collagen upon stimulation with serum, responses that are inhibited by exposure to agents that increase cAMP levels (Fine et al., 1989; Kolodsick et al., 2003) . Furthermore, several responses that we measured mirror those reported for primary fibroblasts isolated from human lung, including reduced growth rate of cells isolated from fibrotic lung (Ramos et al., 2001) . Therefore, the cell lines that we studied here seem to be useful cell culture models of normal and fibrotic pulmonary fibroblasts.
A link between PGE 2 and the cellular anatomy of pulmonary fibrosis has been implied from studies of human samples and animal models of the disease (Wilborn et al., 1995; Ogushi et al., 1999; Vancheri et al., 2000) . Such studies derived from early findings that prostanoids, particularly PGE 2 , regulate pulmonary fibroblast proliferation (Fine and Goldstein, 1987) . Fibrotic lung fibroblasts have decreased expression of cyclooxygenase and reduced PGE 2 production compared with normal pulmonary fibroblasts (Wilborn et al., 1995; Vancheri et al., 2000; Keerthisingam et al., 2001) . PGE 2 seems to act in large part via the stimulation of cAMP production; cAMP, in turn, seems to act at the level of gene transcription and by inhibiting synthesis of certain growth factors (Fine and Goldstein, 1987; Duncan et al., 1999 ). Our results identify another possible alteration in fibroblasts that participates in pulmonary fibrosis: fibrotic fibroblasts have reduced capacity to respond to PGE 2 with changes in gene expression.
PGE 2 is more efficacious than forskolin at inhibiting cell proliferation and collagen synthesis in pulmonary fibroblasts, despite the fact that forskolin stimulated higher levels of cAMP production. Even when tested at higher concentrations than in some of the studies here, forskolin generally did not lead to a level of inhibition equal to that induced by PGE 2 . In addition, PGE 2 inhibited cell proliferation in diseased LL29 cells, albeit to a lesser extent than in normal fibroblasts, whereas other cAMP-elevating agents, including forskolin, were much less effective in this regard. This heterogeneity in responses mediated by PGE 2 , forskolin and other agents may reflect involvement of a signaling pathway other than AC stimulation by PGE 2 , an idea supported by previous studies (Fine et al., 1992; Seternes et al., 1999) . PGE 2 can activate EP 2 and EP 4 receptors (coupled to G s and adenylyl cyclase activation) and in addition, EP 1 and EP 3 receptors (prototypically coupled to G q and activation of phospholipase C). In other types of fibroblasts, EP 2 receptors are critical for PGE 2 -mediated inhibition of collagen synthesis and IP receptors can mediate inhibition of fibroblasts by prostanoids (Choung et al., 1998) . Other, nontraditional signaling pathways activated by EP receptors perhaps contribute to the disparate response to PGE 2 compared with other agents that we tested. Giri et al. (1987) described that signaling via the ␤-adrenergic receptor/adenylyl cyclase system is defective in a rat model of bleomycin-induced pulmonary fibrosis (Giri et al., 1987) . Although these observations differ from our current results (in that we do not observe differences in cAMP generation (Fig. 3) , Giri et al. (1987) reached a similar conclusion regarding impairment in the cAMP pathway as partly responsible for the fibrogenic response. Therefore, fibrogenesis in human lung may share some commonality with experimentally induced pulmonary fibrosis in rodents.
Matrix metalloproteinases and the tissue inhibitors of metalloproteinases play central roles in regulating ECM, and, by association, in the fibrogenic response. cAMP-elevating agents may exert some of their in vivo antifibrotic actions via changes in matrix metalloproteinases and tissue inhibitors of metalloproteinase expression that lead to altered ECM degradation (Liu et al., 2004) and by accelerating the degradation of newly synthesized collagen (Baum et al., 1980) . Our results showing the ability of cAMP to inhibit collagenasesensitive [
3 H]proline incorporation does not seem attributable to stimulatory effects on collagen degradation, since agents that increase cAMP directly inhibit collagen gene expression (Table 2 ) and reduce levels of the procollagen peptide cleaved during collagen processing into ECM (a measure of collagen synthesis not dependent upon incorporation of proline) (Liu et al., 2004) . Thus, although cAMP-elevating Fig. 7 . Forskolin-stimulated and TGF-␤ 1 -inhibited CREB DNA binding is diminished in fibrotic pulmonary fibroblasts. Nuclear extracts from LL47 and LL29 cells treated with either vehicle (control), forskolin (Fsk, 10 M), TGF-␤ 1 (10 ng/ml), or both forskolin and TGF-␤ 1 were incubated with CREB-specific probes and separated by PAGE as described under Materials and Methods. Representative gels images are shown (top). Protein-probe complexes were quantified, adjusted for protein loading (as determined by dye-binding assay) and are shown as the mean Ϯ S.E. of three experiments (bottom). ‫,ء‬ p Ͻ 0.05 by paired t test compared with control. #, p Ͻ 0.05 by t test comparing cell types. †, p Ͻ 0.05 by paired t test comparing forskolin alone. agents may be able to enhance ECM degradation, such activity does not seem to account for the inhibition of collagen synthesis in our experimental paradigm.
Pathogenesis of pulmonary fibrosis is related to the presence and activity of myofibroblasts, a differentiated and activated interstitial fibroblast (Kuhn and McDonald, 1991; Zhang et al., 1994) . We and others have reported that increases in cellular cAMP levels inhibit myofibroblast differentiation (as defined by expression of ␣-SM actin) and have speculated that this effect may be important in attenuating fibrosis (Kolodsick et al., 2003; Liu et al., 2004) . The present data indicating that cAMP-mediated inhibition of myofibroblast differentiation is equally robust in diseased pulmonary fibroblasts as in control fibroblasts (Fig. 4) implies that cAMP-mediated inhibition of collagen synthesis and cell proliferation occur through different signaling pathways. Our data also imply that inhibition of collagen synthesis by cAMP is not a result of its inhibition of myofibroblast differentiation but more likely a consequence of inhibition of collagen gene transcription.
We conclude that a defect exists in the cAMP/PKA/CREB signaling pathway regulating collagen synthesis and cell proliferation in LL29 and LL97A pulmonary fibroblasts cultured from fibrotic human lung. This defect is distal to the generation of cAMP and activation of PKA but seems to occur at the level of activation of CREB and thus ability of CREB to exert transcriptional regulation of cAMP/PKA-regulated genes.
